Sono-Photo Dynamic Therapy (SPDT)
SPDT 4 LIFE’s Division of Oncology is highly regarded internationally thanks largely to the pioneering work and ongoing research carried out by its distinguished head, Professor Xiaohuai Wang, MD.
Dr. Wang’s ground-breaking and innovative accomplishments in the field of Sono-Photo Dynamic Therapy (SPDT) have seen a growing number of patients, many from the Western world, turn to SPDT 4 LIFE for the treatment of late stage cancers – and with tremendous success.
SPDT 4 LIFE views SPDT as the essential non-toxic therapy for metastatic cancer and it lies at the core of the hospital’s successful approach to cancer treatment.
SPDT is a relatively new therapy in the field of cancer treatments. It combines Photo-Dynamic Therapy (PDT) with Sono-Dynamic Therapy (SDT) to destroy tumours in malignant cells.
Dr Wang is the inventor of the specially designed ultrasound bath and SPDT 4 LIFE has exclusive rights to this ground-breaking superior equipment. No other facility anywhere in the world has this technology, which allows for effective and efficient whole-body treatment. Dr Wang is the world’s leading authority on SPDT and the combination of his expertise and the best SPDT equipment available anywhere, ensures that we are the leader in the field of SPDT and second to none.
The combined SPDT approach can be effectively used to combat most types and all stages of cancer, but it has proven to be of particular benefit to late stage cancer patients for whom there exist few effective treatment options. SPDT works synergistically with other advanced cancer treatment modalities – enhancing their efficacy exponentially – including: (low-dose) chemotherapy, Site-Specific Chemotherapy, Radio Seed Implantation, Radio Frequency Ablation, HIFU, immunotherapy, natural therapies, holistic therapies and Traditional Chinese Medicine.
Put simply – PDT involves the patient taking a sensitiser (orally) before being treated with a strong red light. The sensitiser uses light-sensitive compounds that when exposed selectively to light, become toxic to targeted malignant and other diseased cells but does not harm healthy cells
While the PDT approach of using light waves to activate photosynthetic agents in the body-healing process dates back to the ancient Egyptians, first reports of its success in treating solid tumours emanated from Germany in the early 1900s. Since then, hundreds of international studies have confirmed its effectiveness, with the US Food and Drug Administration (FDA) granting approval to PDT in the mid-1970s for the localised treatment of several stages of oesophageal and lung cancers. More recently, new and improved sensitisers have been developed and applied, with superior outcomes. However, as the body is a poor conductor of light, PDT is effective only with tumours located close to accessible surfaces, such as skin and breast cancers.
The advanced SPDT 4 LIFE approach employs a proprietary chlorophyll-based photosensitiser to prepare the body’s cancer cells for systemic elimination using a purposely designed light wave bed. Once activated by the light in the light bed, the photosensitiser transforms into singlet oxygen, which organises programmed cell death and kills the anaerobic cancer cells without damaging normal tissue.
SDT is the use of low level ultrasound – along with different naturally derived sensitisers – to destroy tumours in malignant cells. This sensitiser when hit by the ultrasound waves also becomes toxic to the targeted cancerous cells whilst causing no harm to healthy cells.
SDT is a more recent cancer treatment, having first been applied to human patients little more than a decade ago.
It was developed as a way to reach the deep seated tumours of the body that PDT with its limitations is unable to touch.
It’s critical advantage over PDT is that unlike light, the human body is particularly transparent to ultrasound. The sound waves penetrate the body, successfully attacking deep seated tumours thus making SDT a key treatment for a growing number of patients.
Dr. Wang and his team at SPDT 4 LIFE have been the pioneers and are the worlds leading authority on SDT and SPDT. After many years of research and working closely with world class scientists and engineers, Dr. Wang and his team have designed and built purpose made sensitisers and ultrasound baths that are the most effective and efficient means of administering SDT & SPDT anywhere in the world.
SDT is a twenty first century therapy which can treat almost all tumors, wherever they are in the body. SDT is the key therapy, and PDT is a useful adjunct.
Sono-Photo Dynamic Therapy (SPDT)
SPDT, then, employs both light and sound frequencies to damage and destroy cancer cells in a non-invasive and non-toxic procedure.
In plain language, the sensitising agent primes the tumour cells to specific frequencies but has no effect on regular, healthy cells. Administration of SPDT through localised and whole body routes then causes a reaction within the sensitised tumour cells, which results in the formation of reactive oxygen species, destroying the tumour mass.
As the therapy has minimal side effects and does not damage surrounding tissues, SPDT is increasingly the preferred cancer treatment for those who have not responded to previous treatment – and especially in the case of metastatic cancers.
A wide variety of cancers have been successfully treated using SPDT in conjunction with elements of both Western and Chinese medicine, including advanced breast, prostate, stomach, lung, brain, colorectal, maxillary sinus, skin and epithelial soft tissue cancers.
Key Advantages of SPDT Include:
- As a non-toxic cancer treatment, it can be repeated many times, without loss of effectiveness – the fact that the body can only tolerate a limited amount of toxic drugs and toxic radiation means that, at some point, oncologists exhaust their conventional treatment options.
- As a whole-body therapy and when applied in a water bath fitted with multiple transducers, it attacks cancer wherever it is and whether it has been detected or not.
- Many patients receiving SPDT based treatment enjoy a good quality of life and live considerably longer. We expect many to live happily into old age.
- It is effective with a large range of cancers, even supposedly impossible cancers such as mesothelioma.
- It is synergistic in nature and particularly effective when carried out in combination with low dose chemotherapy.
- When received prior to surgery, pathological evaluation found the excised tumor to be at least partly necrotic.
The downsides are few, namely the limited availability of SPDT in the Western world and the fact that, in some Western countries, the treatment is not covered by state or private health insurance.
SPDT Based Treatment
SPDT and all standard treatments for metastatic cancer are rarely curative. Treatment needs to continue indefinitely. This is almost always impractical with standard treatments. Chemotherapy and radiation therapy are dangerous and too often lose efficacy for longer term use.
SPDT 4 LIFE has added an effective, affordable follow up program which can be used indefinitely to attack any remaining cancer, and any newly developing cancers.
SPDT is the basic treatment to immediately and effectively attack all cancer including metastases. The follow up program maintains that attack on remaining cancer and reduces the risk (or defers the occurrence) of recurring cancer.
We recommend continuing this follow up program until there is no evidence of remaining cancer, and then to take (cheaper) maintenance doses indefinitely.
SPDT Treatment Outcomes
When evaluating patient outcomes, it is important to remember that almost all SPDT patients have tried standard therapies, with minimal, if any, success. By the time they turn to SPDT treatment, the disease has usually progressed, their bodies have been damaged by previous treatments, many are in poor general health and have large cancer loads. They typically have no other reasonable treatment options.
Despite these handicaps, SPDT does amazingly well.
Eminent Melbourne-based Australian scientist Dr. Doug Mitchell – who currently serves as a scientific consultant to the team at SPDT 4 LIFE and has been actively involved in researching the outcomes of SPDT treatment for nearly 10 years – believes some 80% of patients he has worked with have significantly benefited from the treatment, some spectacularly so.
In his words, he says he has seen patients arrive for treatment looking in dreadful health only to emerge a few weeks later looking terrific.
“I recall a patient who arrived at SPDT 4 LIFE in a wheelchair and was coughing constantly. A few months later, we caught up for lunch, there was no coughing and she had just been for a 150-metre swim in the pool,” he said.
“Every doctor I have spoken to who is familiar with SPDT believes it is the best treatment for metastatic cancer. It is also new technology and new technology improves with time, so we can confidently expect even better outcomes as the technology is developed.”
Note also that the patients who fail to benefit from SPDT fail because they have incurred too much damage from the cancer and/or from previous treatment. They have reached a “point of no return” where even if all cancer magically disappeared, they wouldn’t make it because of their pre-existing damage. They are not treatment failures.